Literature DB >> 758923

Slow acetylation phenotype in systemic lupus erythematosus.

E Fishbein, D Alarcón-Segovia.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 758923     DOI： 10.1002/art.1780220118

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

Review 2.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 3.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

4.  Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.

Authors:  Y Horai; T Ishizaki; T Sasaki; G Koya; K Matsuyama; S Iguchi
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Drug acetylation and expression of lupus erythematosus.

Authors:  J R Marsden; G G Mason; P R Coburn; M D Rawlins; S Shuster
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Acetylator polymorphism in discoid lupus erythematosus.

Authors:  J M Ladero; L C Jiménez; M J Fernández; A Robledo
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.